0000905718-18-000480.txt : 20180514 0000905718-18-000480.hdr.sgml : 20180514 20180514161932 ACCESSION NUMBER: 0000905718-18-000480 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180510 FILED AS OF DATE: 20180514 DATE AS OF CHANGE: 20180514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shaknovich Rita CENTRAL INDEX KEY: 0001647566 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35817 FILM NUMBER: 18830884 MAIL ADDRESS: STREET 1: C/O CANCER GENETICS, INC. 201 ROUTE 17N STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER GENETICS, INC CENTRAL INDEX KEY: 0001349929 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 043462475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 BUSINESS PHONE: 201.528.9200 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 FORMER COMPANY: FORMER CONFORMED NAME: CANCER GENETICS INC DATE OF NAME CHANGE: 20060117 4 1 cancergene_fm4may102018.xml OWNERSHIP DOCUMENT X0306 4 2018-05-10 0 0001349929 CANCER GENETICS, INC CGIX 0001647566 Shaknovich Rita C/O CANCER GENETICS, INC. 201 ROUTE 17N 2ND FLOOR RUTHERFORD NJ 07070 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 0.89 2018-05-10 4 A 0 50000 0 A 2028-05-10 Common Stock 50000 50000 D The option award was made in accordance with the terms of the Amended and Restated Cancer Genetics, Inc. 2011 Equity Incentive Plan (the "2011 Plan"). The shares underlying the options shall become vested and exercisable with respect to twenty percent (20%) of the shares on the one-year anniversary of the date of grant and with respect to the remaining eighty percent (80%) of the shares in equal monthly installments on the 10th day of each of the forty-eight (48) calendar months thereafter, provided that the optionee remains a services provider to the Company through each applicable vesting period. The exercise price is the closing price of a share of Common Stock as of the date of grant on the NASDAQ Capital Market in accordance with the terms of the 2011 Plan. /s/ Rita Shaknovich by John A. Roberts, Attorney-in-Fact 2018-05-14